Wall Street Journal Reports IBM May Sell Watson Health Due to Data Challenges and Unprofitability

Mar 29, 2021 | International Laboratory News, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing, Management & Operations

Might this be a sign that AI platforms like Watson still cannot diagnose the wide range of patients’ conditions as accurately as a board-certified clinical pathologist? Computer technology evolves so quickly, products often become obsolete before fulfilling their expected potential. Such, apparently, is the case with Watson, the genius artificial intelligence (AI) brainchild of International Business Machines Corp. (IBM) which was going to revolutionize how healthcare providers diagnose...

Damo Consulting Survey Predicts Future Health Network Spending Will Primarily be on Improving EHRs; Could be Positive Development for Medical Laboratories

Jun 10, 2019 | Laboratory Pathology

Survey shows healthcare providers plan to wait for AI and digital health technologies to mature before making major investments in them Clinical laboratories must develop strategies for connecting to their client doctors’ electronic health record (EHR) systems. Thus, a new survey that predicts most healthcare networks will continue to focus health information technology (HIT) spending on improving their EHRs—rather than investing in artificial intelligence (AI) and digital healthcare—provides...
;